|
|
Volumn 35, Issue 4, 2010, Pages
|
|
Failure of omalizumab in cholinergic urticaria: Clinical dermatology • Concise report
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BILIRUBIN;
CETIRIZINE;
CHLORPHENIRAMINE;
CIMETIDINE;
CROMOGLYCATE DISODIUM;
CYCLOSPORIN A;
DANAZOL;
DESLORATADINE;
DOXEPIN;
FEXOFENADINE;
GABAPENTIN;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HYDROXYZINE;
IMMUNOGLOBULIN E;
KETOTIFEN;
LEVOCETIRIZINE;
LORATADINE;
MIZOLASTINE;
MONTELUKAST;
NIFEDIPINE;
OMALIZUMAB;
PREDNISOLONE;
PROPANTHELINE BROMIDE;
PROPRANOLOL;
RANITIDINE;
ABSENCE OF SIDE EFFECTS;
ADULT;
ARTICLE;
BILIRUBIN BLOOD LEVEL;
BODY WEIGHT;
CASE REPORT;
CHOLINERGIC URTICARIA;
DERMATOLOGY LIFE QUALITY INDEX;
DISEASE SEVERITY;
DRUG DOSE INCREASE;
DRUG TREATMENT FAILURE;
EVENING DOSAGE;
GILBERT DISEASE;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
LOW DRUG DOSE;
MALE;
PRIORITY JOURNAL;
SCORING SYSTEM;
SYMPTOM;
ULTRAVIOLET B RADIATION;
URTICARIA;
ADULT;
ANTI-ALLERGIC AGENTS;
ANTIBODIES, MONOCLONAL;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
TREATMENT FAILURE;
URTICARIA;
|
|
EID: 77951241500
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/j.1365-2230.2009.03748.x Document Type: Article |
|
Times cited : (47)
|
|
References (10)
|
